Effect of interferon-alpha treatment in hemodialysis patients and renal transplant recipients with chronic hepatitis C.
Tokumoto
T
T
Department of Urology, Tokyo Women's Medical University, Japan.
Tanabe
K
K
Ishikawa
N
N
Simizu
T
T
Oshima
T
T
Noguchi
S
S
Gouya
N
N
Nakazawa
H
H
Hashimoto
E
E
Fuchinoue
S
S
Hayashi
N
N
Toma
H
H
D000328:Adult; D004359:Drug Therapy, Combination; D005260:Female; D016174:Hepacivirus / Q000302:isolation & purification; D018937:Hepatitis C Antibodies / Q000097:blood; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000150:complications / Q000601:surgery / Q000628:therapy; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000097:blood; D006435:Renal Dialysis
D018937:Hepatitis C Antibodies; D007166:Immunosuppressive Agents; D016898:Interferon-alpha; D012367:RNA, Viral